The new codes are for describing the infusion of tixagevimab and cilgavimab monoclonal antibody (code XW023X7), and the infusion of other new technology monoclonal antibody (code XW023Y7).
Search the full ICD-10 catalog by:
ICD-10-CM Diagnosis Codes
A00.0 | B99.9 | 1. Certain infectious and parasitic dise ... |
C00.0 | D49.9 | 2. Neoplasms (C00-D49) |
D50.0 | D89.9 | 3. Diseases of the blood and blood-formi ... |
E00.0 | E89.89 | 4. Endocrine, nutritional and metabolic ... |
F01.50 | F99 | 5. Mental, Behavioral and Neurodevelopme ... |
The ICD-10-CM is a catalog of diagnosis codes used by medical professionals for medical coding and reporting in health care settings. The Centers for Medicare and Medicaid Services (CMS) maintain the catalog in the U.S. releasing yearly updates.
When the provider repeats a Pap smear because of an inadequate sample or abnormal results, you'll report a code from R87. 61- Abnormal cytological findings in specimens from cervix uteri.
Vaginal Pap test (Z12. 72) Pap test other genitourinary sites (Z12. 79)
ICD-10 code Z12. 4 for Encounter for screening for malignant neoplasm of cervix is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
Z12. 39 is the correct code to use when employing any other breast cancer screening technique (besides mammogram) and is generally used with breast MRIs.
Z01.419411, Encounter for gynecological examination (general) (routine) with abnormal findings, or Z01. 419, Encounter for gynecological examination (general) (routine) without abnormal findings, may be used as the ICD-10-CM diagnosis code for the annual exam performed by an obstetrician–gynecologist.
Group 1CodeDescriptionZ11.51*Encounter for screening for human papillomavirus (HPV)
ICD-10 code Z12. 39 for Encounter for other screening for malignant neoplasm of breast is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
Z12. 11: Encounter for screening for malignant neoplasm of the colon.
Z12.11. Encounter for screening for malignant neoplasm of colon.
Z12. 31 (Encounter for screening mammogram for malignant neoplasm of breast) is reported for screening mammograms while Z12. 39 (Encounter for other screening for malignant neoplasm of breast) has been established for reporting screening studies for breast cancer outside the scope of mammograms.
Z12. 31, Encounter for screening mammogram for malignant neoplasm of breast, is the primary diagnosis code assigned for a screening mammogram. If the mammogram is diagnostic, the ICD-10-CM code assigned is the reason the diagnostic mammogram was performed.
ICD-10 Code for Other abnormal and inconclusive findings on diagnostic imaging of breast- R92. 8- Codify by AAPC. Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified. Abnormal findings on diagnostic imaging and in function studies, without diagnosis.
When the provider repeats a Pap smear because of an inadequate sample or abnormal results, you’ll report a code from R87.61- Abnormal cytological findings in specimens from cervix uteri.
There’s an impressive list of Excludes1 and Excludes2 notes at the R87.61- level, meaning the list applies to all codes in that subcategory.
Subcategory R87.61- has a lot of codes, so don’t miss two slightly different ones in the middle:
Encounter for routine postpartum follow-up 1 Z39.2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 2 The 2021 edition of ICD-10-CM Z39.2 became effective on October 1, 2020. 3 This is the American ICD-10-CM version of Z39.2 - other international versions of ICD-10 Z39.2 may differ.
Categories Z00-Z99 are provided for occasions when circumstances other than a disease, injury or external cause classifiable to categories A00 -Y89 are recorded as 'diagnoses' or 'problems'. This can arise in two main ways: